Sinequan and gamma-glutamyltransferase increased Patient Reports February 12, 2012



Sinequan Side Effects Report #4896920-4
Sinequan side effect was reported by a Pharmacist from UNITED KINGDOM on Jan 19, 2006. Female patient, 64 years of age, was diagnosed with ill-defined disorder and was treated with Sinequan. After drug was administered, patient experienced the following side effects: anticholinergic syndrome, aspartate aminotransferase increased, blood alkaline phosphatase increased, disorientation, dry mouth, gamma-glutamyltransferase increased, incorrect dose administered, vision blurred. Sinequan dosage: 40 MG (10 MG, 4 IN 1 D), ORAL. During the same period patient was treated with DAPSONE, MINOCYCLINE, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.

Sinequan Side Effects Report #4904896-6
Sinequan side effect was reported by a Health Professional from UNITED KINGDOM on Jan 25, 2006. Female patient, 64 years of age, was diagnosed with ill-defined disorder and was treated with Sinequan. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, disorientation, dry mouth, gamma-glutamyltransferase increased, incorrect dose administered, vision blurred. Sinequan dosage: 40 MG (10 MG, 4 IN 1 D), ORAL. During the same period patient was treated with DAPSONE, MINOCIN, MORPHINE SULPHATE. Patient was hospitalized and became disabled. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Sinequan